Martin Gouldstone

Chief Executive Officer at ONCE HLDG

Net worth: 5 179 $ as of 31/05/2026

59 year

4 connections

Commercial Services

Health Technology

Technology Services

Profile

Martin John Gouldstone is Chief Executive Officer & Director at Oncimmune Holdings Plc since 2023.
He is Chief Executive Officer at Oncimmune Germany.
GmbH.
He is Independent Non-Executive Chairman at ValiRx Plc since 2024.
He is Independent Non-Executive Director at hVIVO Holdings Ltd. since 2022.
Former roles include Independent Non-Executive Director at hVIVO PLC from 2022 to 2025.
Director at Novara Therapeutics Ltd. Director-Corporate Advisory & Head-Life Sciences at BDO UK LLP from 2015 to 2017.
Director-Business Development at Sareum Ltd. from 2006 to 2008.
Director at Orthopaedic Research UK from 2019 to 2024.
Partner at Results Healthcare from 2017 to 2018.
Chief Business Development Officer at Arcturis Data Ltd. from 2021 to 2022.
Global Senior Vice President-Business Development at Owkin, Inc. Chief Business Officer at BenevolentAI SA from 2018 to 2019.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
VALIRX PLC 0.27%	21/11/2025	1,969,231 ( 0.27% )	5 179 $	31/05/2026

Martin Gouldstone active positions

Companies	Position	Start
ONCE HLDG	Chief Executive Officer	01/08/2023
HVIVO PLC	Director/Board Member	01/06/2022
VALIRX PLC	Chairman	25/07/2024
Oncimmune Germany GmbH Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform	Chief Executive Officer	-

All active positions of Martin Gouldstone

Former positions of Martin Gouldstone

Companies	Position	End
HVIVO PLC	Director/Board Member	05/06/2025
Orthopaedic Research UK Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Provides business support services	Director/Board Member	01/03/2024
SENSYNE HEALTH PLC	Corporate Officer/Principal	01/05/2022
BENEVOLENTAI S.A.	Corporate Officer/Principal	01/01/2019
Results Healthcare Results Healthcare Investment ManagersFinance Provides advisory services	Corporate Officer/Principal	01/06/2018

See the detail of Martin Gouldstone's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Gouldstone's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
ValiRx Plc ValiRx Plc Pharmaceuticals: MajorHealth Technology Develops novel technologies and products in oncology therapeutics and diagnostics	Health Technology
hVIVO Holdings Ltd. hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services	Commercial Services
Sareum Ltd. Sareum Ltd. Drugstore ChainsRetail Trade Provides drug discovery services	Retail Trade
Results Healthcare Results Healthcare Investment ManagersFinance Provides advisory services	Finance
Oncimmune Holdings Plc Oncimmune Holdings Plc BiotechnologyHealth Technology Provides cancer detection and diagnosis services	Health Technology
Orthopaedic Research UK Orthopaedic Research UK Miscellaneous Commercial ServicesCommercial Services Provides business support services	Commercial Services
Owkin, Inc. Owkin, Inc. Packaged SoftwareTechnology Services Develops AI technology that accelerates drug discovery by combining multimodal patient data and large language models	Technology Services
Sensyne Health Ltd. Sensyne Health Ltd. Miscellaneous Commercial ServicesCommercial Services Provides statistical analyses and advanced insights to the healthcare industry	Commercial Services
BDO UK LLP BDO UK LLP Miscellaneous Commercial ServicesCommercial Services Provides tax, audit & assurance, advisory and business outsourcing services	Commercial Services
hVIVO PLC hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services	Commercial Services
Oncimmune Germany GmbH Oncimmune Germany GmbH BiotechnologyHealth Technology Develops antibody and autoantibody biomarker discovery platform	Health Technology
BenevolentAI SA BenevolentAI SA Packaged SoftwareTechnology Services Develops AI drug discovery platform to accelerate biopharma drug discovery	Technology Services